ESR1 and ductal breast carcinoma in situ: Approximately 50~75% of DCIS were ER and/or PR-positive tumors, and reported expression rates of ER and/or PR in microinvasive carcinoma ranged from 50~68% [7–10], similar to the findings in our study.